vs

Side-by-side financial comparison of CPI Card Group Inc. (PMTS) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

CPI Card Group Inc. is the larger business by last-quarter revenue ($153.1M vs $142.0M, roughly 1.1× Oncology Institute, Inc.). CPI Card Group Inc. runs the higher net margin — 4.8% vs -5.3%, a 10.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 22.3%). CPI Card Group Inc. produced more free cash flow last quarter ($35.2M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 16.9%).

CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

PMTS vs TOI — Head-to-Head

Bigger by revenue
PMTS
PMTS
1.1× larger
PMTS
$153.1M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+19.2% gap
TOI
41.6%
22.3%
PMTS
Higher net margin
PMTS
PMTS
10.1% more per $
PMTS
4.8%
-5.3%
TOI
More free cash flow
PMTS
PMTS
$33.0M more FCF
PMTS
$35.2M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
16.9%
PMTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PMTS
PMTS
TOI
TOI
Revenue
$153.1M
$142.0M
Net Profit
$7.3M
$-7.5M
Gross Margin
31.5%
Operating Margin
12.0%
-4.9%
Net Margin
4.8%
-5.3%
Revenue YoY
22.3%
41.6%
Net Profit YoY
8.5%
43.0%
EPS (diluted)
$0.62
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PMTS
PMTS
TOI
TOI
Q4 25
$153.1M
$142.0M
Q3 25
$138.0M
$136.6M
Q2 25
$129.8M
$119.8M
Q1 25
$122.8M
$104.4M
Q4 24
$125.1M
$100.3M
Q3 24
$124.8M
$99.9M
Q2 24
$118.8M
$98.6M
Q1 24
$111.9M
$94.7M
Net Profit
PMTS
PMTS
TOI
TOI
Q4 25
$7.3M
$-7.5M
Q3 25
$2.3M
$-16.5M
Q2 25
$518.0K
$-17.0M
Q1 25
$4.8M
$-19.6M
Q4 24
$6.8M
$-13.2M
Q3 24
$1.3M
$-16.1M
Q2 24
$6.0M
$-15.5M
Q1 24
$5.5M
$-19.9M
Gross Margin
PMTS
PMTS
TOI
TOI
Q4 25
31.5%
Q3 25
29.7%
Q2 25
30.9%
Q1 25
33.2%
Q4 24
34.1%
Q3 24
35.8%
Q2 24
35.7%
Q1 24
37.1%
Operating Margin
PMTS
PMTS
TOI
TOI
Q4 25
12.0%
-4.9%
Q3 25
9.4%
-5.9%
Q2 25
7.3%
-9.4%
Q1 25
11.5%
-9.5%
Q4 24
12.7%
-11.9%
Q3 24
14.3%
-13.9%
Q2 24
12.5%
-16.6%
Q1 24
12.6%
-19.0%
Net Margin
PMTS
PMTS
TOI
TOI
Q4 25
4.8%
-5.3%
Q3 25
1.7%
-12.1%
Q2 25
0.4%
-14.2%
Q1 25
3.9%
-18.8%
Q4 24
5.4%
-13.1%
Q3 24
1.0%
-16.1%
Q2 24
5.1%
-15.7%
Q1 24
4.9%
-21.0%
EPS (diluted)
PMTS
PMTS
TOI
TOI
Q4 25
$0.62
$-0.04
Q3 25
$0.19
$-0.14
Q2 25
$0.04
$-0.15
Q1 25
$0.40
$-0.21
Q4 24
$0.56
$-0.14
Q3 24
$0.11
$-0.18
Q2 24
$0.51
$-0.17
Q1 24
$0.46
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PMTS
PMTS
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$21.7M
Total DebtLower is stronger
$286.7M
Stockholders' EquityBook value
$-17.3M
$-15.7M
Total Assets
$403.2M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PMTS
PMTS
TOI
TOI
Q4 25
$21.7M
Q3 25
$16.0M
Q2 25
$17.1M
Q1 25
$31.5M
Q4 24
$33.5M
Q3 24
$14.7M
Q2 24
$7.5M
$9.9M
Q1 24
$17.1M
$29.8M
Total Debt
PMTS
PMTS
TOI
TOI
Q4 25
$286.7M
Q3 25
$308.4M
Q2 25
$310.9M
Q1 25
$280.7M
Q4 24
$280.4M
Q3 24
$280.2M
Q2 24
$269.7M
Q1 24
$265.3M
Stockholders' Equity
PMTS
PMTS
TOI
TOI
Q4 25
$-17.3M
$-15.7M
Q3 25
$-25.7M
$-12.3M
Q2 25
$-29.0M
$-9.0M
Q1 25
$-29.7M
$5.1M
Q4 24
$-35.6M
$3.6M
Q3 24
$-42.8M
$15.5M
Q2 24
$-44.6M
$29.2M
Q1 24
$-48.5M
$41.3M
Total Assets
PMTS
PMTS
TOI
TOI
Q4 25
$403.2M
$164.7M
Q3 25
$407.1M
$163.6M
Q2 25
$399.8M
$159.8M
Q1 25
$351.9M
$164.0M
Q4 24
$349.7M
$172.7M
Q3 24
$342.3M
$179.2M
Q2 24
$321.4M
$179.6M
Q1 24
$319.8M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PMTS
PMTS
TOI
TOI
Operating Cash FlowLast quarter
$39.6M
$3.2M
Free Cash FlowOCF − Capex
$35.2M
$2.2M
FCF MarginFCF / Revenue
23.0%
1.5%
Capex IntensityCapex / Revenue
2.9%
0.7%
Cash ConversionOCF / Net Profit
5.39×
TTM Free Cash FlowTrailing 4 quarters
$41.3M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PMTS
PMTS
TOI
TOI
Q4 25
$39.6M
$3.2M
Q3 25
$10.0M
$-12.6M
Q2 25
$4.3M
$-10.2M
Q1 25
$5.6M
$-5.0M
Q4 24
$26.7M
$4.2M
Q3 24
$12.5M
$819.0K
Q2 24
$-4.8M
$-15.7M
Q1 24
$8.9M
$-15.9M
Free Cash Flow
PMTS
PMTS
TOI
TOI
Q4 25
$35.2M
$2.2M
Q3 25
$5.3M
$-13.2M
Q2 25
$533.0K
$-11.4M
Q1 25
$292.0K
$-5.3M
Q4 24
$21.6M
$2.4M
Q3 24
$11.1M
$417.0K
Q2 24
$-6.0M
$-17.5M
Q1 24
$7.4M
$-16.5M
FCF Margin
PMTS
PMTS
TOI
TOI
Q4 25
23.0%
1.5%
Q3 25
3.8%
-9.7%
Q2 25
0.4%
-9.5%
Q1 25
0.2%
-5.1%
Q4 24
17.3%
2.4%
Q3 24
8.9%
0.4%
Q2 24
-5.0%
-17.7%
Q1 24
6.6%
-17.4%
Capex Intensity
PMTS
PMTS
TOI
TOI
Q4 25
2.9%
0.7%
Q3 25
3.4%
0.4%
Q2 25
2.9%
1.0%
Q1 25
4.3%
0.3%
Q4 24
4.0%
1.8%
Q3 24
1.2%
0.4%
Q2 24
1.0%
1.9%
Q1 24
1.3%
0.6%
Cash Conversion
PMTS
PMTS
TOI
TOI
Q4 25
5.39×
Q3 25
4.32×
Q2 25
8.39×
Q1 25
1.17×
Q4 24
3.94×
Q3 24
9.70×
Q2 24
-0.79×
Q1 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PMTS
PMTS

US Debit And Credit$128.9M84%
US Prepaid Debit$24.4M16%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons